Comparison
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063 vs 10q22 3q23 3 Microduplication Syndrome C5190512
Clinical comparison between 17 Alpha Hydroxylase 7 20 Lyase Deficiency CN380063 and 10q22 3q23 3 Microduplication Syndrome for differential diagnosis and treatment planning.
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
A rare genetic disorder affecting steroid hormone production. Causes ambiguous genitalia, lack of puberty, and high blood pressure. Requires lifelong hormone replacement therapy.
10q22 3q23 3 Microduplication Syndrome C5190512
A rare genetic condition where a small amount of chromosomal material is duplicated, causing varied developmental differences. Requires comprehensive medical evaluation.
6 comparison axes
Onset
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
0-18
10q22 3q23 3 Microduplication Syndrome C5190512
0-null
Onset patterns differ
Severity
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
severe
10q22 3q23 3 Microduplication Syndrome C5190512
moderate
Different severity levels
Chronic
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
Chronic
10q22 3q23 3 Microduplication Syndrome C5190512
Chronic
Differing course
Communicable
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
No
10q22 3q23 3 Microduplication Syndrome C5190512
No
Different transmission
Body System
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
endocrine
10q22 3q23 3 Microduplication Syndrome C5190512
congenital
Same/different system
Category
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
endocrine
10q22 3q23 3 Microduplication Syndrome C5190512
genetic
Different category
Bottom line
17-alpha-hydroxylase-7-20-lyase-deficiency-CN380063 and 10q22-3q23-3-microduplication-syndrome-C5190512 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063 | 10q22 3q23 3 Microduplication Syndrome C5190512 | Discriminating power |
|---|---|---|---|
| Genital and pubertal development | Ambiguous genitalia or absent puberty may occur from impaired sex-steroid production. | These features are not established as characteristic; developmental differences vary. | High |
| Blood pressure | Hypertension may occur and can begin in childhood or adolescence. | Hypertension is not an established defining feature. | Moderate |
| Development | The core pattern is endocrine rather than a broad chromosomal syndrome. | Developmental differences may vary widely among affected people. | Moderate |
When to favor each condition
Choose 17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063 when
Ambiguous genitalia, delayed puberty, and hypertension
This combination better fits disordered steroid production than a microduplication.
High
Steroid testing suggests a 17-hydroxylase/lyase block
A compatible biochemical pattern supports specialist endocrine evaluation.
Moderate
CYP17A1-related genetic confirmation
Gene confirmation distinguishes this disorder from a chromosomal duplication.
High
Choose 10q22 3q23 3 Microduplication Syndrome C5190512 when
Microarray identifies a 10q22.3q23.3 duplication
Direct chromosomal evidence supports the microduplication diagnosis.
High
Developmental differences without a steroidogenic pattern
Absence of the endocrine pattern makes the left diagnosis less likely.
Moderate
Family chromosomal studies are informative
Inheritance and breakpoint assessment require genetics interpretation.
Moderate
How key tests differ
| Test | 17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063 | 10q22 3q23 3 Microduplication Syndrome C5190512 | Interpretation |
|---|---|---|---|
| Steroid hormone profile | May suggest reduced cortisol and sex steroids with mineralocorticoid excess. | No characteristic steroid abnormality is established. | Results require endocrine interpretation; cutoffs are not supplied here. |
| Chromosomal microarray | Not expected to show this specific duplication. | May detect extra material at 10q22.3q23.3. | Array findings need laboratory and clinical correlation. |
| Blood pressure and electrolytes | Hypertension or electrolyte imbalance may be present. | No specific blood-pressure or electrolyte pattern is established. | Abnormal results are findings, not diagnoses by themselves. |
Prognosis comparison
17 Alpha Hydroxylase 7 20 Lyase Deficiency Cn380063
- Outcome
- Often chronic and potentially severe, but individual outcome is not fixed by the label.
- Factors
- Blood-pressure control, hormone management, and age at recognition may matter.
10q22 3q23 3 Microduplication Syndrome C5190512
- Outcome
- Often chronic with moderate but highly variable developmental impact.
- Factors
- Duplication content, associated findings, and support needs influence course.
Time frame: Childhood through adulthood; exact course is not established.
Confirmed diagnosis, associated anomalies, treatment response, and access to specialist care.
Complications comparison
| Complication | Presentation |
|---|---|
| Hypertension | May be clinically important and require long-term monitoring. Not established as a typical complication. Management should be individualized by clinicians. |
| Reproductive development | Puberty and fertility may be affected; replacement may be lifelong. Reproductive effects are not established from the supplied data. Counseling should follow confirmed findings. |
| Developmental needs | Not described as the primary feature. Learning or developmental support needs may vary. Assessment should be comprehensive and person-specific. |
Patient education highlights
- HighSpecialist confirmation
Both are rare; diagnosis depends on appropriate genetic or endocrine testing and clinical review.
- HighTransmission
Neither condition is communicable. Inheritance counseling differs and should be individualized.
- MediumFollow-up
Monitoring plans vary. Do not use an abnormal test alone to predict outcome.